|Articles|March 20, 2023
Size exclusion chromatography to determine AAV titers
Author(s)Thermo Fisher Scientific
This customer note will demonstrate the suitability of SEC for a fast and reproducible evaluation of adeno-associated virus (AAV) product titers
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
FAQ: What You Need to Know About How Industry is Tackling CGT Bottlenecks
3
Drug Digest: Biopharma Landscape Evolves Through Strategic Alliances and Technology Integration
4
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
5
